Posts by: Anna Tan, RN

Anna Tan, RN

Anna is responsible for the scripting and production of video news content. Her skills as a registered nurse as well as a proven video content creator on YouTube and other social media platforms allow her to create video news reports that are engaging and easy to understand for patients.

October 28, 2015November 6, 2015

Alitair Presents Updates on Bronchiectasis Treatments at 2015 Cavendish Forum

Bronchiectasis, News

Clinical stage pharmaceutical company Alitair Pharmaceuticals is currently presenting at the ongoing Cavendish Global Health Impact Forum in Cleveland, Ohio, which kicked off Sunday, October 25, and concludes on October 28th. The forum ... Read more

October 28, 2015November 9, 2015

COPD Affects 1.1 Million California Residents, UCLA Report Reveals

COPD, News

In 2011, the Center for Health Policy Research at the University of California, Los Angeles, released an alarming report on the prevalence of chronic obstructive pulmonary disease (COPD) among adults ... Read more

October 27, 2015November 9, 2015

BREATHE LA to Host 7th Annual COPD Conference in mid-November

COPD, News

BREATHE California of Los Angeles (BREATHE LA), a nonprofit organization established in 1903 and dedicated to creating clean air and healthy lungs for Los Angeles County residents, is preparing to host ... Read more

October 27, 2015November 5, 2015

Vertex and CRISPR Therapeutics Partner to Advance Gene Therapies for Cystic Fibrosis, Sickle Cell

Cystic Fibrosis, News

Vertex Pharmaceuticals, Inc., and CRISPR Therapeutics announced a new strategic research partnership focused on utilizing the CRISPR-Cas9 gene editing platform in the potential discovery and development of new gene therapies. The companies plan to focus ... Read more

October 26, 2015November 5, 2015

Trends in IPF Patient Care, Disease Progression Highlighted in IPF-PRO Registry

Idiopathic Pulmonary Fibrosis, News

Boehringer Ingelheim Pharmaceuticals, Inc., recently released a report highlighting the first batch of findings based on 49 idiopathic pulmonary fibrosis patients enrolled in the IPF-PRO Registry — an academic-industry partnership between Boehringer and the Duke ... Read more

October 22, 2015November 9, 2015

Yoga Aids COPD Patients in Ways Comparable to Traditional Pulmonary Rehabilitation Methods, Study Shows

COPD, News

Scientists from the Department of Pulmonary Medicine and Sleep Disorders and All India Institute of Medical Sciences in New Delhi, India, recently published their findings from studying the benefits of yoga ... Read more

October 21, 2015November 9, 2015

Sunovion to Present Updates on Brovana (arformoterol tartrate) for COPD Maintenance During CHEST 2015

COPD, News

Sunovion Pharmaceuticals, Inc., a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions, recently announced it will be attending the ... Read more

October 6, 2015November 5, 2015

EMA Validates PTC Therapeutics’ Submission for New Nonsense Mutation Cystic Fibrosis Indication for Translarna (Ataluren)

Cystic Fibrosis, News

The European Medicines Agency (EMA) recently accepted a submission of variation for a new indication from PTC Therapeutics regarding Translarna (ataluren) for nonsense mutation cystic fibrosis (nmCF), which would allow the drug ... Read more

September 30, 2015November 6, 2015

Severe Asthma Takes Control of Everyday Life, Boston Scientific Patient Survey Shows

Asthma, News

Boston Scientific recently conducted an extensive patient survey that sought to better understand the impact asthma has made and continues to make on the lives of more than 850 patients ... Read more

September 28, 2015September 28, 2015

CHMP Issues Positive Recommendation for ORKAMBI and KALYDECO in the EU

News

Biotechnology company Vertex Pharmaceuticals, Inc. recently announced that the European Union Committee for Medicinal Products for Human Use (CHMP) has released a positive opinion and recommendation for Marketing Authorization of breakthrough ... Read more